20-Feb-14 8:00 AM  CST

Consistent Aspirin Use Could Possibly Help In Reducing Ovarian Cancer Risk

Approximately over 20,000 women in the United States will be possibly diagnosed with ovarian cancer this year and 14,000 will die from it.      

            Women may benefit from the use of a daily aspirin may be able to cut their risk of ovarian cancer by 20% according to a new study lead by scientists at the National Cancer Institute which is part of the National Institutes of Health (NIH). 

            Britton Trabert, a member of the NCI’s Division of Cancer Epidemiology recently commented on the study’s findings.  “Our study suggests that aspirin regimens, proven to protect against heart attack, may reduce the risk of ovarian cancer as well.  However intriguing our results are, they should not influence current clinical practice.  Additional studies are needed to explore the delicate balance of risk-benefit for this potential chemo preventive agent, as well as studies to identify the mechanism by which aspirin may reduce ovarian cancer risk,” said Trabert.

            The use of acetaminophen, however, is not associated with the risk reduction of ovarian cancer.  It should also be noted that daily aspirin use could produce some adverse side-effects such as upper GI bleeding and hemorrhagic stroke.  Early detection and treatment continues to be the best defense in the war against ovarian cancer and other types of cancer. 

            The NCI study was published in the February 6th edition of the Journal of the National Cancer Institute.     

 


Sources: 

 

1.  Johnsen, Michael.  “Study:  Daily Aspirin Use May Reduce Risk of Ovarian Cancer by 20%.”  Drug Store News.  Web.  Date of Access:  17 Feb 2014. 

 

2.  NCI Press Release.  “NIH Study Finds Regular Aspirin Use May Reduce Cancer Risk.”  National Cancer Institute.  Web.  Date of Access” 17 Feb 2014. 

 

 


For additional information on this article, please contact:
 
Jennifer O'Reilly
 
Source: Jennifer S. O’Reilly for NPTA  

Tendenci™ User Home © 2004 Tendenci™ software by Schipul - "The Web Marketing Company" | www.schipul.com